- Home
- EHTH vs KOD Comparison
EHTH vs KOD Comparison
Compare EHTH & KOD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EHTH
- KOD
- Stock Information
- Founded
- EHTH 1997
- KOD 2009
- Country
- EHTH United States
- KOD United States
- Employees
- EHTH N/A
- KOD N/A
- Industry
- EHTH Specialty Insurers
- KOD Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- EHTH Finance
- KOD Health Care
- Exchange
- EHTH Nasdaq
- KOD Nasdaq
- Market Cap
- EHTH 105.1M
- KOD 198.4M
- IPO Year
- EHTH 2006
- KOD 2018
- Fundamental
- Price
- EHTH $3.85
- KOD $9.21
- Analyst Decision
- EHTH Buy
- KOD Hold
- Analyst Count
- EHTH 4
- KOD 4
- Target Price
- EHTH $8.50
- KOD $11.75
- AVG Volume (30 Days)
- EHTH 268.4K
- KOD 484.4K
- Earning Date
- EHTH 11-05-2025
- KOD 11-13-2025
- Dividend Yield
- EHTH N/A
- KOD N/A
- EPS Growth
- EHTH N/A
- KOD N/A
- EPS
- EHTH N/A
- KOD N/A
- Revenue
- EHTH $547,491,000.00
- KOD N/A
- Revenue This Year
- EHTH $4.99
- KOD N/A
- Revenue Next Year
- EHTH $3.41
- KOD N/A
- P/E Ratio
- EHTH N/A
- KOD N/A
- Revenue Growth
- EHTH 16.19
- KOD N/A
- 52 Week Low
- EHTH $3.18
- KOD $1.92
- 52 Week High
- EHTH $11.36
- KOD $11.60
- Technical
- Relative Strength Index (RSI)
- EHTH 49.68
- KOD 51.51
- Support Level
- EHTH $3.82
- KOD $8.91
- Resistance Level
- EHTH $4.09
- KOD $9.93
- Average True Range (ATR)
- EHTH 0.20
- KOD 0.75
- MACD
- EHTH -0.00
- KOD -0.15
- Stochastic Oscillator
- EHTH 23.81
- KOD 39.48
About EHTH eHealth Inc.
eHealth Inc is a company involved in private health insurance marketplace with a technology and service platform that provides consumer engagement, education and health insurance enrollment solutions. The company operates its business in two segments: Medicare which provides health insurance plans and lesser extent ancillary products such as dental and vision insurance and hospital indemnity plans, to medicare eligible consumers; and Employer and Individual provides individual and family health insurance, and small business health insurance plans and Individual Coverage Health Reimbursement Arrangements. It derives maximum revenue from Medicare Segment. All of the company's revenue is from the United States. It also has a presence in China.
About KOD Kodiak Sciences Inc
Kodiak Sciences Inc is a biopharmaceutical company specializing in novel therapeutics to treat high-prevalence retinal diseases. The product candidate of the company is BLA, which is a novel antibody biopolymer conjugate, in treatment-naive subjects with neovascular wet AMD. The pipeline products of the company include Tarcocimab tedromer, KSI-501, and KSI-101.